| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.26 |
0.0002 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |